isoxazoles has been researched along with Acute Brain Injuries in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaberel, T; Gakuba, C; Lépine, M; Lo, EH; van Leyen, K; Zheng, Y | 1 |
| Gatson, JW; Simpkins, JW; Uteshev, VV | 1 |
| Boychuk, JA; Butler, CR; Halmos, KC; Smith, BN | 1 |
| Fernández-Ruiz, J; García-Arencibia, M; García-Toscano, L; Gómez-Cañas, M; Jagerovic, N; Morales, P; Muñoz, E; Navarrete, C; Pazos, MR | 1 |
| Boychuk, JA; Butler, CR; Smith, BN | 1 |
| Kelly, KM; Kharlamov, EA; Lepsveridze, E; Lu, B; Mtchedlishvili, Z; Xu, H | 1 |
6 other study(ies) available for isoxazoles and Acute Brain Injuries
| Article | Year |
|---|---|
Impact of 12/15-Lipoxygenase on Brain Injury After Subarachnoid Hemorrhage.
Topics: Animals; Arachidonate 12-Lipoxygenase; Arachidonate 15-Lipoxygenase; Brain Injuries; Disease Models, Animal; Isoxazoles; Lipoxygenase Inhibitors; Macrophages; Mice; Mice, Knockout; Naphthalenes; Oxidative Stress; Subarachnoid Hemorrhage | 2019 |
High therapeutic potential of positive allosteric modulation of α7 nAChRs in a rat model of traumatic brain injury: proof-of-concept.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Anti-Inflammatory Agents; Astrocytes; Brain Injuries; Cholinergic Agents; Disease Models, Animal; Gliosis; Hippocampus; Immunohistochemistry; In Situ Nick-End Labeling; Isoxazoles; Male; Neurons; Neuroprotective Agents; Phenylurea Compounds; Rats, Sprague-Dawley | 2015 |
Enduring changes in tonic GABAA receptor signaling in dentate granule cells after controlled cortical impact brain injury in mice.
Topics: Anesthetics; Animals; Brain Injuries; Cerebral Cortex; Dentate Gyrus; Desoxycorticosterone; Disease Models, Animal; Electric Stimulation; Functional Laterality; GABA Agonists; Gene Expression Regulation; Imidazoles; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Isoxazoles; Male; Mice; Neurons; Receptors, GABA-A; RNA, Messenger; Signal Transduction | 2016 |
Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile.
Topics: Animals; Binding Sites; Blood-Brain Barrier; Brain; Brain Injuries; Cannabinoid Receptor Agonists; Cell Line; Disease Models, Animal; Humans; Isoxazoles; Male; Malonates; Mice; Models, Biological; Nerve Degeneration; Neurons; Neuroprotective Agents; Permeability; Protein Binding; Rats, Wistar; Receptor, Cannabinoid, CB2; Transfection | 2016 |
Differential effects of rapamycin treatment on tonic and phasic GABAergic inhibition in dentate granule cells after focal brain injury in mice.
Topics: Anesthetics; Animals; Brain Injuries; Dentate Gyrus; Disease Models, Animal; Functional Laterality; GABA Agents; GABAergic Neurons; Glutamate Decarboxylase; Green Fluorescent Proteins; Immunosuppressive Agents; In Vitro Techniques; Interneurons; Isoxazoles; Male; Membrane Potentials; Mice; Mice, Transgenic; Patch-Clamp Techniques; Ribosomal Protein S6 Kinases; Sirolimus; Time Factors | 2016 |
Increase of GABAA receptor-mediated tonic inhibition in dentate granule cells after traumatic brain injury.
Topics: Animals; Brain Injuries; Dentate Gyrus; Diazepam; Furosemide; GABA Agonists; GABA Modulators; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; Hippocampus; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Isoxazoles; Male; Neural Inhibition; Neurons; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Synapses; Temperature; Time Factors | 2010 |